Zur Seitenansicht
 

Titelaufnahme

Titel
Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC
VerfasserSchülke, Stefan ; Wolfheimer, Sonja ; Gadermaier, Gabriele ; Wangorsch, Andrea ; Siebeneicher, Susanne ; Briza, Peter In der Gemeinsamen Normdatei der DNB nachschlagen ; Spreitzer, Ingo ; Schiller, Dirk ; Loeschner, Bettina ; Uematsu, Satoshi ; Ryffel, Bernard ; Akira, Shizuo ; Waibler, Zoe ; Vieths, Stefan ; Toda, Masako ; Scheurer, Stephan
Erschienen in
PLoS ONE, Lawrence, Kan., 2014, Jg. 9, S. 1-12
ErschienenPublic Library of Science, 2014
SpracheEnglisch
DokumenttypAufsatz in einer Zeitschrift
Schlagwörter (EN)Secretion / Flagellin / Cell fusion / Mouse models / Cytokines / T cells / Vaccination and immunization / Enzyme-linked immunoassays
ISSN1932-6203
URNurn:nbn:at:at-ubs:3-3182 Persistent Identifier (URN)
DOI10.1371/journal.pone.0087822 
Zugriffsbeschränkung
 Das Werk ist frei verfügbar
Dateien
Prevention of intestinal allergy in mice by rflaA:Ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC [0.85 mb]
Links
Nachweis
Klassifikation
Zusammenfassung (Englisch)

Conjugated vaccines consisting of flagellin and antigen activate TLR5 and induce strong innate and adaptive immune responses. Objective of the present study was to gain further insight into the mechanisms by which flagellin fusion proteins mediate their immune modulating effects. In a mouse model of Ova-induced intestinal allergy a fusion protein of flagellin and Ova (rflaA:Ova) was used for intranasal and intraperitoneal vaccination. Aggregation status of flaA, Ova and flaA:Ova were compared by light scattering, uptake of fluorescence labeled proteins into mDC was analyzed, processing was investigated by microsomal digestion experiments. Mechanism of DC-activation was investigated using proteasome and inflammasome inhibitors. Immune responses of wildtype, IL-10/, TLR5/ mDCs and Ova-transgenic T cells were investigated. Mucosal and i.p.-application of rflaA:Ova were able to prevent allergic sensitization, suppress disease-related symptoms, prevent body weight loss and reduction in food uptake. Intranasal vaccination resulted in strongest suppression of Ova-specific IgE production. These protective effects were associated with increased aggregation of rflaA:Ova and accompanied by tenfold higher uptake rates into mDC compared to the mixture of both proteins. Microsomal digestion showed that stimulation with rflaA:Ova resulted in faster degradation and the generation of different peptides compared to rOva. rflaA:Ova-mediated activation of mDC could be suppressed in a dose-dependent manner by the application of both inflammasome and proteasome inhibitors. Using TLR5/ mDC the rflaA:Ova induced IL-10 secretion was shown to be TLR5 dependent. In co-cultures of IL-10/ mDC with DO11.10 T cells the lack of rflaA:Ova-mediated IL-10 secretion resulted in enhanced levels of both TH2 (IL-4, IL-5) and TH1 (IL-2 and IFN-y) cytokines. In summary, mucosal vaccination with flaA:Ova showed strongest preventive effect. Stimulation with rflaA:Ova results in strong immune modulation mediated by enhanced uptake of the aggregated fusion protein, likely resulting in a different processing by DC as well as stronger TLR5 mediated cell activation.

Lizenz
CC-BY-NC-ND-Lizenz (4.0)Creative Commons Namensnennung - Nicht kommerziell - Keine Bearbeitung 4.0 International Lizenz